MOD Live 2022

Leslie O’Dell, OD, FAAO

Medical Director 
Director of Clinical Research 
Medical Optometry America 
York, PA 

Justin Schweitzer, OD, FAAO

Vance Thompson Vision
Sioux Falls, SD

William B. Trattler, MD

Cornea, Cataract, and Refractive Surgeon
Center for Excellence in Eye Care
Clinical Associate Professor
Herbert Wertheim College of Medicine
Florida International University
Miami, FL

Walter O. Whitley, OD, MBA, FAAO

Director of Professional Relations and Education
Virginia Eye Consultants
Norfolk, VA

DISCLOSURE POLICY
It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent financial relationships relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all financial relationships prior to this educational activity.

The following faculty/staff members have the following financial relationships with ineligible companies.

Leslie O’Dell, OD, FAAO, has had a financial agreement or affiliation with the following ineligible companies in the form of Consultant: Alcon, Alderya, Allergan, Bausch + Lomb, EyeDetech, Eye Eco, Johnson & Johnson Vision, Kala Pharmaceuticals, Novartis, Ocuphire, Oyster Point, Sight Sciences, Sun Pharmaceutical Industries, and Tarsus Pharmaceuticals. Speaker's Bureau: Aerie Pharmaceuticals, Alcon, Allergan/AbbVie, Bausch + Lomb, Kala Pharmaceuticals, Oyster Point Pharma, and Sun Pharmaceutical Industries. Stock/Shareholder: Eyes are the Story, EyeDetech, and Medical Optometry America.

Justin Schweitzer, OD, FAAO, has had a financial agreement or affiliation with the following ineligible companies in the form of Consultant: Aerie, Alcon, Allergan, Bausch + Lomb, Ocular Therapeutix, EyePoint Pharma, Sight Sciences, Dompé, Carl Zeiss Meditec, Visus, Science Based Health, Kala, Sun, Reichert, Johnson & Johnson, Glaukos, Horizon, Quidel, MediPrint, LKC, Avellino, and Novartis. Speaker's Bureau: Aerie, Alcon, Allergan, Bausch + Lomb, Sight Sciences, Carl Zeiss Meditec, Sun, Glaukos, and LKC. Investor: Equinox.

William B. Trattler, MD, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Alcon, Allergan, Avellino, Azura Ophthalmics, Bausch + Lomb, Beaver-Visitec International, Bio-Tissue, Carl Zeiss Meditec, Glaukos, Johnson & Johnson Vision, Kala Pharmaceuticals, Lensar, Oculus, Sight Sciences, and Sun Ophthalmics. Speaker’s Bureau: Alcon, Allergan, Avellino, Bausch + Lomb, Beaver-Visitec International, Carl Zeiss Meditec, Johnson & Johnson Vision, Kala Pharmaceuticals, Lensar, Oculus, Sight Sciences, and Sun Ophthalmics. Stock/Shareholder: ArcScan and Visionary Fund.

Walter O. Whitley, OD, MBA, FAAO, has had a financial agreement or affiliation with the following ineligible companies in the form of Consultant: Aerie Pharmaceuticals, Alcon Vision, Allergan/AbbVie, Astareal, Bausch + Lomb, Bruder Healthcare, BMC, Dompé, Eyevance, Heru, Horizon Therapeutics, Johnson & Johnson Vision, Kala Pharmaceuticals, Novartis, Oyster Point Pharma, Quidel, Regener-Eyes, RVL Pharmaceuticals, ScienceBased Health, Sun Pharmaceutical Industries, Tarsus Pharmaceuticals, ThermaMEDx, and Visus. Speaker’s Bureau: Aerie Pharmaceuticals, Alcon Vision, Allergan/AbbVie, Bausch + Lomb, Kala Pharmaceuticals, Oyster Point Pharma, ScienceBased Health, and Sun Pharmaceutical Industries. Share/Stockholder: MediPrint Pharma.

Joseph Allen, OD, FAAO, has had a financial agreement or affiliation with the following ineligible companies in the form of Consultant: Myze, Avellino Labs, Tear Restore, and Gamer Advantage. Content Creator: Alcon, Coopervision, Transitions, Maculogix, Orcam, Ocusoft, Marchon, VSP, Axon Optics, Christopher Cloos, EyeEco, Randolph Engineering, JINS Eyewear, Visionology, and OptaZoom. Stock/Shareholder: MYZE, Tear Restore, and Engage Technologies Group.

Alison Bozung, OD, has had no financial agreement or affiliation with an ineligible company.

Joshua Davidson, OD, FSLS, FAAO, has had a financial agreement or affiliation with the following ineligible companies in the form of Consultant: Santen (Eyevance), kala, Gaukos, and Oyster Point. Speaker: Allergan, Santen (Eyevance), Kala, Glaukos, and Oyster Point. Grant/Research Support: Santen (Eyevance). Employee and Shareholder: Dry Eye Drink.

Doug Devries, OD, has had a financial agreement or affiliation with the following ineligible companies in the form of Consultant: Allergan/Abbvie, Alcon, TearLab, Quidel, BioTissue, Tear Science, Dompé, Kala, Oyster Point, Johnson & Johnson Vision, Azura, Avelino, Bruder, Bausch Health, EyeVance, Lumenis, OcuSoft, Science Based Health, Tarsus, Visus, Orasis, Novartis, Sun, and Thea. Speaker's Bureau: Allergan/Abbvie, Alcon, Quidel, BioTissue, Tear Science, Dompé, Kala, Oyster Point, Johnson & Johnson Vision, Bausch Health, EyeVance, Lumenis, OcuSoft, Science Based Health, Novartis, and Sun. Stock/Shareholder: Ophthalmic Resources.

Ahmad M. Fahmy, OD, FAAO, Dipl ABO, has had a financial agreement or affiliation with the following ineligible companies in the form of Consultant: Allergan, Sun Ophthalmics, and Kala. Speaker's Bureau: Allergan, NuSight Medical, and BioTissue.

Jaclyn Garlich, OD, FAAO, has had a financial agreement or affiliation with the following ineligible companies in the form of Consultant: Allergan, Dompé, Lumenis, Novartis, Orasis, Tarsus, Thea Pharmaceuticals, Bruder, Kala Pharmaceuticals, and Oyster Point.

Marie Huegel, OD, has had no financial agreement or affiliation with an ineligible company.

Josh Johnston, OD, FAAO, has had a financial agreement or affiliation with the following ineligible companies in the form of Speaker's Bureau: Allergan, Astareal, Avellino, Azura, BioTissue, Bruder, Dompe, Glaukos, Horizon Therapeutics, Johnson & Johnson, Kala, LacriSciences, Sight Sciences, Maxi Vision, Sun Pharma, and Quidel.

Hardeep Kataria, OD, FAAO, has had a financial agreement or affiliation with the following ineligible companies in the form of Consultant: Tarsus Pharmaceuticals.

Cecelia Koetting, OD, FAAO, has had a financial agreement or affiliation with the following ineligible companies in the form of Consultant: Dompé, Tarsus, RVL, Eyevance/Santen, Alcon, Allergan, Orasis, Visus, Bruder, Kala, Thea, Ivantis, and Oyster Point. Speaker's Bureau: Dompé, RVL, Alcon, Ivantis, and Oyster Point. Grant/Research Support: Johnson & Johnson.

Elise Kramer, OD, FAAO, FSLS, has had a financial agreement or affiliation with the following ineligible companies in the form of Consultant: Avellino, Allergan and RegenerEyes. Speaker's Bureau: Contamac, Dompé, and Visionary Optics.

Jacob Lang, OD, FAAO, has had a financial agreement or affiliation with the following ineligible companies in the form of Consultant: Allergan, Novartis, Ocular Therapeutics, AOS, SCOPE, Orasis, Quiedel, Dompé, Oyster Point, Kala, Aldeyra, and Aerie. Speaker's Bureau: Sun Pharma, Dompé, and Oyster Point.

Jessilin Quint, OD, MBA, MS, FAAO, has had a financial agreement or affiliation with the following ineligible companies in the form of Consultant: Allergan, Alcon, Tarsus, and Eyenovia. Speaker's Bureau: Allergan.

Sherrol Reynolds, OD, FAAO, has had a financial agreement or affiliation with the following ineligible companies in the form of Speaker's Bureau: VSP Global. Advisory Board: Allergan.

Nick Risbrudt, OD, has had a financial agreement or affiliation with the following ineligible companies in the form of Speaker's Bureau: Avellino.

Emilie Seitz, OD, has had a financial agreement or affiliation with the following ineligible companies in the form of Consultant: WALDO. Content Creator: twenty/twenty beauty, CooperVision, Avenova, and Nanodropper.

Diana Shechtman, OD, FAAO, has had no financial agreement or affiliation with an ineligible company.

Allison W. Shuren, JD has had no financial agreement or affiliation with an ineligible company.

I. Paul Singh, MD, has had a financial agreement or affiliation with the following ineligible companies in the form of Consultant: Bausch + Lomb, Allergan, Alcon, Sight Sciences, New World Med, Glaucos, Ocular Therapeutics, Raynor, Imdrimes, Ocuphire, and BUI. Speaker's Bureau: Bausch + Lomb, Allergan, Alcon, Sight Sciences, New World Med, Glaucos, Ocular Therapeutics, Raynor, Imdrimes, Ocuphire, Tracey Technologies, IStar Medical, and BUI. Grant/Research Support: Allergan, Sight Sciences, New World Medical, Elios, Glaucos, Ocular Therapeutics, and IStart Medical.

Will To, OD, ABOC has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Bausch + Lomb, The Vision Council, and Transitions Optical. Speakers Bureau: Bausch + Lomb, Optos, Sight Sciences, and Marketing4ECPs.

Rachael Wruble, OD, FAAO, has had a financial agreement or affiliation with the following ineligible companies in the form of Speaker's Bureau: Allergan and Bausch + Lomb.

Larae Zimprich, OD, FAAO, has had no financial agreement or affiliation with an ineligible company.

The Evolve and the Avenue Live staff and planners have no financial relationships with ineligible companies.